How to buy Biophytis SA American Depositary Share stock

Biophytis SA American Depositary Share is a biotechnology business based in the US. Biophytis SA American Depositary Share shares (BPTS) are listed on the NASDAQ and all prices are listed in US Dollars. Biophytis SA American Depositary Share employs 25 staff and has a market cap (total outstanding shares value) of 0.00.

Biophytis SA American Depositary Share share price

Use our graph to track the performance of BPTS stocks over time.

Biophytis SA American Depositary Share shares at a glance

• Key figures

Information last updated 2021-03-24.

52-week range	$13.50 - $18.50
50-day moving average	$15.38
200-day moving average	$15.38
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy Biophytis SA American Depositary Share shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Biophytis SA American Depositary Share stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Biophytis SA American Depositary Share by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Biophytis SA American Depositary Share financials

Gross profit TTM	$0
Return on assets TTM	-38.83%
Return on equity TTM	0%
Profit margin	0%
Book value	N/A
Market capitalisation	$157.6 million

TTM: trailing 12 months

Shorting Biophytis SA American Depositary Share shares

There are currently 1,107 Biophytis SA American Depositary Share shares held short by investors – that's known as Biophytis SA American Depositary Share's "short interest". This figure is 83.2% down from 6,574 last month.

There are a few different ways that this level of interest in shorting Biophytis SA American Depositary Share shares can be evaluated.

Biophytis SA American Depositary Share's "short interest ratio" (SIR)

Biophytis SA American Depositary Share's "short interest ratio" (SIR) is the quantity of Biophytis SA American Depositary Share shares currently shorted divided by the average quantity of Biophytis SA American Depositary Share shares traded daily (recently around 27675). Biophytis SA American Depositary Share's SIR currently stands at 0.04. In other words for every 100,000 Biophytis SA American Depositary Share shares traded daily on the market, roughly 40 shares are currently held short.

To gain some more context, you can compare Biophytis SA American Depositary Share's short interest ratio against those of similar companies.

• CVS Health Corporation (CVS.US): 2.33
• UnitedHealth Group Incorporated (UNH.US): 2.08
• McKesson Corporation (MCK.US): 3

However Biophytis SA American Depositary Share's short interest can also be evaluated against the total number of Biophytis SA American Depositary Share shares, or, against the total number of tradable Biophytis SA American Depositary Share shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Biophytis SA American Depositary Share's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Biophytis SA American Depositary Share shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Biophytis SA American Depositary Share shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Biophytis SA American Depositary Share.

Find out more about how you can short Biophytis SA American Depositary Share stock.

Biophytis SA American Depositary Share share dividends

We're not expecting Biophytis SA American Depositary Share to pay a dividend over the next 12 months.

You may also wish to consider:

• CVS Health Corporation (CVS.US) (2.39% forward annual dividend yield)
• UnitedHealth Group Incorporated (UNH.US) (1.2% forward annual dividend yield)
• McKesson Corporation (MCK.US) (0.9% forward annual dividend yield)

Biophytis SA American Depositary Share share price volatility

Over the last 12 months, Biophytis SA American Depositary Share's shares have ranged in value from as little as $13.5 up to $18.5. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biophytis SA American Depositary Share's is 1.1982. This would suggest that Biophytis SA American Depositary Share's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put Biophytis SA American Depositary Share's beta into context you can compare it against those of similar companies.

• CVS Health Corporation (CVS.US): 0.8155
• UnitedHealth Group Incorporated (UNH.US): 0.7765
• McKesson Corporation (MCK.US): 0.8786

Biophytis SA American Depositary Share overview

Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases and the treatment of severe respiratory failure in patients suffering from COVID-19. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD). Its second drug candidate, Macuneos (BIO201), is an orally administered small molecule in development for the treatment of retinal diseases, including dry ager elated macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is based in Paris, France. .

Frequently asked questions

How many people work for Biophytis SA American Depositary Share?
Latest data suggests 25 work at Biophytis SA American Depositary Share. When does the fiscal year end for Biophytis SA American Depositary Share?
Biophytis SA American Depositary Share's fiscal year ends in December. Where is Biophytis SA American Depositary Share based?
Biophytis SA American Depositary Share's address is: Sorbonne University, Paris, France, 75005